GC
녹십자홀딩스 · 005250
Industrials Commercial Services · KOSPI
Market cap US$386.4M (₩533.3B)
Overview
GC (녹십자홀딩스) is a holding company, a parent entity that owns and oversees a group of operating subsidiaries, whose businesses span pharmaceutical manufacturing, blood diagnostics and genetic analysis, healthcare services, and real estate leasing, all listed on KOSPI, Korea's main stock exchange.
Its products and services reach patients, healthcare providers, and other end-users through its subsidiary companies rather than directly. The pharmaceutical manufacturing and distribution arm accounts for the largest share of consolidated revenue, with diagnostics and healthcare services making up most of the remainder.
Summary is AI-generated and may contain errors · figures from DART filings
Financials
Source: DART · FY ending Dec · latest FY2025Revenue
- FY2023US$1.5B
- FY2024US$1.6B
- FY2025US$1.8B
Operating profit
- FY2023−US$11.9M
- FY2024−US$7.8M
- FY2025US$26.3M
Net income
- FY2023−US$52.7M
- FY2024−US$8M
- FY2025−US$30.3M
Key ratios (FY2025)
Why it matters
GC acts as the strategic and portfolio-management parent for its subsidiaries, including its principal operating subsidiary 녹십자, while the subsidiaries themselves conduct the actual business operations.
Price charts coming soon
Interactive price history isn't here yet. Would you use it?